Modern Diagnostic SME IPO From Dec 31
The price band has been fixed at ₹85 to ₹90 per equity share, each with a face value of ₹10
Mumbai: Gurugram-based Modern Diagnostic & Research Centre, a provider of diagnostic and allied healthcare testing services in India, has announced the launch of its initial public offering (IPO) on December 31, 2025. The SME IPO, which aims to raise ₹36.89 crore, will close on January 2, 2026.
The issue comprises a fresh offering of 40.99 lakh equity shares and is proposed to be listed on the BSE SME platform. The price band has been fixed at ₹85 to ₹90 per equity share, each with a face value of ₹10.
Modern Diagnostic operates a network of 21 centres, including 17 laboratories and four diagnostic centres, spread across eight states—Haryana, Uttar Pradesh, Madhya Pradesh, Assam, West Bengal, Rajasthan, Jammu & Kashmir, and Punjab. The company caters to individual patients, hospitals, and corporate clients.
The net proceeds from the IPO will be utilised towards capital expenditure for the purchase of advanced medical equipment for diagnostic centres and laboratories, meeting working capital requirements, repayment of certain outstanding borrowings, and general corporate purposes.
Commenting on the IPO, Devendra Singh Yadav, Chairman and Managing Director of Modern Diagnostic & Research Centre, said, “The proposed IPO will strengthen our financial position and support our expansion strategy. The funds will be deployed to acquire advanced medical equipment, enhance our diagnostic and laboratory infrastructure, and expand our network of centres. This will improve testing capabilities, reduce turnaround times, and ensure consistent, high-quality diagnostic services across all our locations.”